Femme et Homme
- | Pays :
- Korea, Republic of
- | Organes : -
- | Spécialités : -
Extrait
To investigate the safety and tolerability of a 28 day course of intravenous (IV) MG1102 in patients with solid tumors for which no standard therapy is available.
Critère d'inclusion
- Solid Tumors